Table 2

Symptoms and comorbidities of children and SARS-CoV-2 test results for those presenting with COVID-19 like symptoms

TotalPositiveNegativeOR (95% CI)P value for OR
n=319 (76.3%)n=135 (42.3%)n=184 (57.7%)
Screening symptoms distribution, n (%)
 Fever190 (59.6)83 (61.5)107 (58.2)1.1 (0.8 to 1.4)0.55
 Cough190 (59.6)82 (60.7)108 (58.7)1.1 (0.7 to 1.7)0.71
 Rhinorrhoea125 (39.2)57 (42.2)68 (37.0)1.0 (0.6 to 1.6)0.95
 Sore throat81 (25.4)27 (20)54 (29.4)0.6 (0.4 to 1.0)0.06
 Diarrhoea58 (18.2)36 (26.7)22 (12.0)2.7 (1.5 to 4.8)0.001
 Headache58 (18.2)22 (16.3)36 (19.6)0.8 (0.4 to 1.4)0.46
 Asthenia53 (16.6)22 (16.3)31 (16.8)1.0 (0.5 to 1.7)0.90
 Myalgia42 (13.2)24 (17.8)18 (9.8)2.0 (1.0 to 3.8)0.04
 Vomiting21 (6.6)9 (6.7)12 (6.5)1.1 (0.3 to 3.8)0.83
 Difficulty breathing or shortness of breath16 (5.0)7 (5.2)9 (4.9)1.1 (0.4 to 2.9)0.90
 Loss of taste5 (1.6)3 (2.2)2 (1.1)2.1 (0.3 to 12.6)0.42
 Loss of smell3 (0.9)2 (1.5)1 (0.5)2.8 (0.2 to 30.7)0.41
Other symptoms
 Skin rash13 (4.1)7 (5.2)6 (3.3)1.6 (0.5 to 4.9)0.39
 Conjunctivitis10 (3.1)7 (5.2)3 (1.6)3.3 (0.8 to 13.0)0.08
 Chest pain or pressure10 (3.1)4 (3.0)6 (3.3)0.9 (0.3 to 3.3)0.88
 Loss of colour on the fingers of the hands or feet3 (0.9)1 (0.7)2 (1.1)0.7 (0.1 to 7.6)0.75
 Loss of speech and movement1 (0.3)1 (0.7)0 (0)nd
Comorbidities
 Respiratory diseases40 (12.5)21 (15.6)19 (10.3)1.6 (0.8 to 3.1)0.17
 Cardiovascular diseases12 (3.8)10 (7.4)2 (1.1)7.3 (1.6 to 33.8)0.01
 Obesity6 (1.9)3 (2.2)3 (1.6)1.4 (0.3 to 6.9)0.70
 Cancer1 (0.3)0 (0)1 (0.5)nd
 Kawasaki disease1 (0.3)1 (0.7)0 (0)nd
  • P values for the bivariate models are indicated in the rightmost column.

  • Bold values are considered statistically significant.

  • *ORs generated using logistic regression modelling with 95% CI.

  • nd, not determined.